Healthpeak Properties
DOC
18.66
-0.34
-1.79%
Healthpeak Properties
US · DOC
#1197 by market cap
Listed 1970
18.66
-0.34
-1.79%
Live - 5344 symbols - heartbeat 7s ago
· 2026-10-08 07:27
Pre-market
18.58
-0.43%
After-hours
18.66
0.00%
Overnight
18.73
+0.38%
- Market cap
- 12.87B
- P/E (TTM)i
- 53.31
- P/Bi
- 1.64
- EPSi
- 0.10
- Div yieldi
- 6.54%
- 52W posi
- 48%
Reader sentiment
Are you bullish or bearish on DOC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 8 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.2 percentage points.
Institutional ownership
- Held by institutions
- 97.97% -0.22pp
- Institutions
- 914 -8
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund84.26%
Public Company3.73%
Hedge Fund3.25%
Private Company2.42%
Government Pension Fund1.67%
Sovereign Wealth Fund1.37%
Corporate Pension Plan0.37%
Individual/Insider0.31%
Insurance Company0.22%
Other2.41%
Top holders as of 2026-06-30
BlackRock
10.29% · 70.94M sh
Vanguard Portfolio Management, LLC
8.47% · 58.38M sh
Vanguard Capital Management, LLC
7.09% · 48.89M sh
State Street Global Advisors
6.38% · 44.01M sh
Fuller & Thaler Asset Management, Inc.
4.22% · 29.12M sh
Geode Capital Management, LLC
3.58% · 24.65M sh
Principal Global Investors, LLC
2.44% · 16.82M sh
J.P. Morgan Asset Management, Inc.
2.42% · 16.71M sh
Invesco Capital Management LLC
2.40% · 16.55M sh
Charles Schwab Investment Management
1.73% · 11.94M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
28 filings tracked · 13 buys · 15 sells
| Name | Role | Stake |
|---|---|---|
| John Thomas | Chief Executive Officer | 0.12% |
| Thomas Thompson | Independent Non-Executive Chairman & Lead Trustee | 0.02% |
| Richard Weiss | Officer | 0.01% |
| Pamela Shelley-Kessler | Officer | 0.01% |
| Ava Lias-Booker | Officer | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2024-01-17 | Del Mar Taylor | Chief Investment Officer | Derivative Exercise and Sale | -28,074 | $12.95 |
| 2024-01-17 | Del Mar Taylor | Chief Investment Officer | Derivative Exercise and Retained | +42,898 | -- |
| 2024-01-17 | John Thomas | Chief Executive Officer | Derivative Exercise and Sale | -46,394 | $12.95 |
| 2024-01-17 | John Thomas | Chief Executive Officer | Derivative Exercise and Retained | +103,487 | -- |
| 2024-01-17 | Bradley Page | Senior VP & General Counsel | Derivative Exercise and Sale | -18,084 | $12.95 |
| 2024-01-17 | Bradley Page | Senior VP & General Counsel | Derivative Exercise and Retained | +19,137 | -- |
| 2024-01-17 | W. Dukes | Senior Vice President of Asset Management | Derivative Exercise and Sale | -1,883 | $12.95 |
| 2024-01-17 | W. Dukes | Senior Vice President of Asset Management | Derivative Exercise and Retained | +1,868 | -- |
| 2024-01-17 | Jeffrey Theiler | Executive VP, CFO & Head of Investor Relations | Derivative Exercise and Sale | -31,590 | $12.95 |
| 2024-01-17 | Jeffrey Theiler | Executive VP, CFO & Head of Investor Relations | Derivative Exercise and Retained | +39,382 | -- |
| 2024-01-17 | John Lucey | Chief Accounting & Administrative Officer | Derivative Exercise and Sale | -18,619 | $12.95 |
| 2024-01-17 | John Lucey | Chief Accounting & Administrative Officer | Derivative Exercise and Retained | +20,369 | -- |
| 2024-01-17 | Mark Theine | Executive Vice President of Asset Management | Derivative Exercise and Sale | -26,833 | $12.95 |
| 2024-01-17 | Mark Theine | Executive Vice President of Asset Management | Derivative Exercise and Retained | +30,278 | -- |
| 2024-01-17 | Daniel Klein | Senior VP & Deputy Chief Investment Officer | Derivative Exercise and Sale | -16,006 | $12.95 |
| 2024-01-17 | Daniel Klein | Senior VP & Deputy Chief Investment Officer | Derivative Exercise and Retained | +17,678 | -- |
| 2024-01-17 | Amy Hall | Senior Vice President of Leasing & Physician Strategy | Derivative Exercise and Sale | -8,198 | $12.95 |
| 2024-01-17 | Amy Hall | Senior Vice President of Leasing & Physician Strategy | Derivative Exercise and Retained | +14,329 | -- |
| 2024-01-17 | Laurie Becker | Senior Vice President | Derivative Exercise and Sale | -16,300 | $12.95 |
| 2024-01-17 | Laurie Becker | Senior Vice President | Derivative Exercise and Retained | +17,384 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:27:45 · For reference only, not investment advice and not tailored to your situation.